ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Glenmark Pharmaceuticals gets ANDA approval for multiple sclerosis drug
October 10, 2020Glenmark’s current portfolio consists of 164 products authorised for distribution in the US marketplace and 46 ANDA’s pending approval with the US FDA. -
Forward pharma loses Tecfidera patent appeal against Biogen
October 25, 2018Forward Pharma has lost its appeal on a US Patent Trial and Appeal Board decision that validated patents for Biogen's blockbuster MS drug Tecfidera (dimethyl fumarate).
Pharma Sources Insight January 2025
